135 related articles for article (PubMed ID: 11642497)
1. Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: the University of Nebraska experience.
Pavletic SZ; Odell JR; Pirruccello SJ; Ursick MM; Haire CE; Sharp JG; Kessinger A; Klassen LW
J Rheumatol Suppl; 2001 Oct; 64():13-20. PubMed ID: 11642497
[TBL] [Abstract][Full Text] [Related]
2. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
[TBL] [Abstract][Full Text] [Related]
3. Autologous stem cell transplantation for rheumatoid arthritis--interim report of 6 patients.
Bingham SJ; Snowden J; McGonagle D; Richards S; Isaacs J; Morgan G; Emery P
J Rheumatol Suppl; 2001 Oct; 64():21-4. PubMed ID: 11642498
[TBL] [Abstract][Full Text] [Related]
4. Intensive immunosuppression and autologous stem cell transplantation for patients with severe rheumatoid arthritis: the Leiden experience.
van Laar JM; Verburg RJ; Fibbe WE; Breedveld FC
J Rheumatol Suppl; 2001 Oct; 64():25-7. PubMed ID: 11642499
[TBL] [Abstract][Full Text] [Related]
5. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy.
Verburg RJ; Kruize AA; van den Hoogen FH; Fibbe WE; Petersen EJ; Preijers F; Sont JK; Barge RM; Bijlsma JW; van de Putte LB; Breedveld FC; van Laar JM
Arthritis Rheum; 2001 Apr; 44(4):754-60. PubMed ID: 11315914
[TBL] [Abstract][Full Text] [Related]
6. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients.
Burt RK; Georganas C; Schroeder J; Traynor A; Stefka J; Schuening F; Graziano F; Mineishi S; Brush M; Fishman M; Welles C; Rosen S; Pope R
Arthritis Rheum; 1999 Nov; 42(11):2281-5. PubMed ID: 10555021
[TBL] [Abstract][Full Text] [Related]
7. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis.
Moore J; Brooks P; Milliken S; Biggs J; Ma D; Handel M; Cannell P; Will R; Rule S; Joske D; Langlands B; Taylor K; O'Callaghan J; Szer J; Wicks I; McColl G; Passeullo F; Snowden J
Arthritis Rheum; 2002 Sep; 46(9):2301-9. PubMed ID: 12355477
[TBL] [Abstract][Full Text] [Related]
8. High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities.
van Oosterhout M; Verburg RJ; Levarht EW; Moolenburgh JD; Barge RM; Fibbe WE; van Laar JM
Ann Rheum Dis; 2005 Dec; 64(12):1783-5. PubMed ID: 16284342
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of severe systemic autoimmune diseases with autologous peripheral blood stem cell transplantation].
Zhao Y; Zhou DB; Leng XM; Wang SJ; Li TS; Duan Y; Shen T; Zhao YQ; Zhang JP; Bai LJ; Cui W; Zhang FQ; Zeng XF; Zhang FC; Dong Y; Tang FL
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2077-81. PubMed ID: 15730620
[TBL] [Abstract][Full Text] [Related]
10. Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppression.
Bohgaki T; Atsumi T; Bohgaki M; Furusaki A; Kondo M; Sato-Matsumura KC; Abe R; Kataoka H; Horita T; Yasuda S; Amasaki Y; Nishio M; Sawada K; Shimizu H; Koike T
J Rheumatol; 2009 Jun; 36(6):1240-8. PubMed ID: 19447934
[TBL] [Abstract][Full Text] [Related]
11. Treatment of relapse after autologous blood stem cell transplantation for severe rheumatoid arthritis.
Pavletic SZ; Klassen LW; Pope R; O'Dell JR; Traynor AE; Haire CE; Graziano F; Oyama Y; Barr W; Burt RK
J Rheumatol Suppl; 2001 Oct; 64():28-31. PubMed ID: 11642500
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis.
Snowden JA; Biggs JC; Milliken ST; Fuller A; Brooks PM
Arthritis Rheum; 1999 Nov; 42(11):2286-92. PubMed ID: 10555022
[TBL] [Abstract][Full Text] [Related]
13. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
Cassinotti A; Annaloro C; Ardizzone S; Onida F; Della Volpe A; Clerici M; Usardi P; Greco S; Maconi G; Porro GB; Deliliers GL
Gut; 2008 Feb; 57(2):211-7. PubMed ID: 17895357
[TBL] [Abstract][Full Text] [Related]
14. Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis.
Statkute L; Oyama Y; Barr WG; Sufit R; Ho S; Verda L; Loh Y; Yaung K; Quigley K; Burt RK
Ann Rheum Dis; 2008 Jul; 67(7):991-7. PubMed ID: 17947303
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
16. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
[TBL] [Abstract][Full Text] [Related]
17. Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim.
Damon L; Rugo H; Tolaney S; Navarro W; Martin T; Ries C; Case D; Ault K; Linker C
Biol Blood Marrow Transplant; 2006 Mar; 12(3):316-24. PubMed ID: 16503501
[TBL] [Abstract][Full Text] [Related]
18. Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration.
Verburg RJ; Flierman R; Sont JK; Ponchel F; van Dreunen L; Levarht EW; Welling MM; Toes RE; Isaacs JD; van Laar JM
Ann Rheum Dis; 2005 Oct; 64(10):1397-405. PubMed ID: 15829573
[TBL] [Abstract][Full Text] [Related]
19. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
20. Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation.
Kashyap A; Snowden J
J Rheumatol Suppl; 2001 Oct; 64():39-41. PubMed ID: 11642503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
